141 related articles for article (PubMed ID: 34555371)
1. Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Howard BV; Umans J; Sitlani CM; Siscovick DS; King IB; Djousse L; Sotoodehnia N; Lemaitre RN
J Lipid Res; 2021; 62():100119. PubMed ID: 34555371
[TBL] [Abstract][Full Text] [Related]
2. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
[TBL] [Abstract][Full Text] [Related]
3. Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study.
Fretts AM; Jensen PN; Hoofnagle A; McKnight B; Howard BV; Umans J; Yu C; Sitlani C; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
J Nutr; 2020 May; 150(5):1214-1222. PubMed ID: 31665380
[TBL] [Abstract][Full Text] [Related]
4. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
[TBL] [Abstract][Full Text] [Related]
5. Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.
Lemaitre RN; Jensen PN; Hoofnagle A; McKnight B; Fretts AM; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N
Circ Heart Fail; 2019 Jul; 12(7):e005708. PubMed ID: 31296099
[TBL] [Abstract][Full Text] [Related]
6. Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
Clin Chem; 2021 Nov; 67(12):1650-1659. PubMed ID: 34580702
[TBL] [Abstract][Full Text] [Related]
7. Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.
Jensen PN; Fretts AM; Hoofnagle AN; Sitlani CM; McKnight B; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N; Lemaitre RN
J Am Heart Assoc; 2020 Feb; 9(4):e012853. PubMed ID: 32019406
[TBL] [Abstract][Full Text] [Related]
8. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
[TBL] [Abstract][Full Text] [Related]
9. Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.
Fretts AM; Jensen PN; Sitlani CM; Hoofnagle A; Lidgard B; Umans JG; Siscovick DS; King IB; Howard BV; Cole SA; Lemaitre RN
J Am Heart Assoc; 2024 Jun; ():e032536. PubMed ID: 38904223
[TBL] [Abstract][Full Text] [Related]
10. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study.
Lemaitre RN; Fretts AM; Sitlani CM; Biggs ML; Mukamal K; King IB; Song X; Djoussé L; Siscovick DS; McKnight B; Sotoodehnia N; Kizer JR; Mozaffarian D
Am J Clin Nutr; 2015 May; 101(5):1047-54. PubMed ID: 25787996
[TBL] [Abstract][Full Text] [Related]
11. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.
Forouhi NG; Koulman A; Sharp SJ; Imamura F; Kröger J; Schulze MB; Crowe FL; Huerta JM; Guevara M; Beulens JW; van Woudenbergh GJ; Wang L; Summerhill K; Griffin JL; Feskens EJ; Amiano P; Boeing H; Clavel-Chapelon F; Dartois L; Fagherazzi G; Franks PW; Gonzalez C; Jakobsen MU; Kaaks R; Key TJ; Khaw KT; Kühn T; Mattiello A; Nilsson PM; Overvad K; Pala V; Palli D; Quirós JR; Rolandsson O; Roswall N; Sacerdote C; Sánchez MJ; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
Lancet Diabetes Endocrinol; 2014 Oct; 2(10):810-8. PubMed ID: 25107467
[TBL] [Abstract][Full Text] [Related]
12. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
[TBL] [Abstract][Full Text] [Related]
13. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
[TBL] [Abstract][Full Text] [Related]
14. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study.
Fretts AM; Mozaffarian D; Siscovick DS; Djousse L; Heckbert SR; King IB; McKnight B; Sitlani C; Sacks FM; Song X; Sotoodehnia N; Spiegelman D; Wallace ER; Lemaitre RN
J Am Heart Assoc; 2014 Jun; 3(3):e000889. PubMed ID: 24970268
[TBL] [Abstract][Full Text] [Related]
15. Circulating Very-Long-Chain SFA Concentrations Are Inversely Associated with Incident Type 2 Diabetes in US Men and Women.
Ardisson Korat AV; Malik VS; Furtado JD; Sacks F; Rosner B; Rexrode KM; Willett WC; Mozaffarian D; Hu FB; Sun Q
J Nutr; 2020 Feb; 150(2):340-349. PubMed ID: 31618417
[TBL] [Abstract][Full Text] [Related]
16. Very long-chain saturated fatty acids and diabetes and cardiovascular disease.
Lemaitre RN; King IB
Curr Opin Lipidol; 2022 Feb; 33(1):76-82. PubMed ID: 34907969
[TBL] [Abstract][Full Text] [Related]
17. Associations of circulating very-long-chain saturated fatty acids and incident type 2 diabetes: a pooled analysis of prospective cohort studies.
Fretts AM; Imamura F; Marklund M; Micha R; Wu JHY; Murphy RA; Chien KL; McKnight B; Tintle N; Forouhi NG; Qureshi WT; Virtanen JK; Wong K; Wood AC; Lankinen M; Rajaobelina K; Harris TB; Djoussé L; Harris B; Wareham NJ; Steffen LM; Laakso M; Veenstra J; Samieri C; Brouwer IA; Yu CI; Koulman A; Steffen BT; Helmer C; Sotoodehnia N; Siscovick D; Gudnason V; ; Wagenknecht L; Voutilainen S; Tsai MY; Uusitupa M; Kalsbeek A; Berr C; Mozaffarian D; Lemaitre RN
Am J Clin Nutr; 2019 Apr; 109(4):1216-1223. PubMed ID: 30982858
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte Saturated Fatty Acids and Incident Type 2 Diabetes in Chinese Men and Women: A Prospective Cohort Study.
Lin JS; Dong HL; Chen GD; Chen ZY; Dong XW; Zheng JS; Chen YM
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30275386
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease.
You Q; Peng Q; Yu Z; Jin H; Zhang J; Sun W; Huang Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830858
[TBL] [Abstract][Full Text] [Related]
20. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
